Finding your way out of hormonal chaos is achievable but not always easy. Did you know 75% of women have mild to severe symptoms as they move into menopause and 50-80% of women experience PMS? Meaning that statistically, hormonal based symptoms will affect most women during their lifetime.
Hormones typically act in one part per trillion and can be embedded in a complex cyclical and bio-feedback system that make resolving hormone based conditions and finding underlying causes very challenging.
What Symptoms and Conditions Are We Talking About Here?
Most women may experience the odd irregular cycle, slightly more ‘crampy’ than normal period, or a minor mood fluctuation in the latter couple of weeks of her cycle – however, experiencing a regular problem and/or discomfort, though common, is most definitely not normal and therefore should be assessed by a health professional so it can be resolved. Though female reproductive cycle issues can come in a range of shapes and sizes, some of the most common seen clinically are listed below:
- PMS:symptoms of fluid retention, breast tenderness, anxiety, depression and food cravings occurring in the two weeks before menstruation.
- Dysmenorrhoea:painful menstruation.
- Menorrhagia:heavy menstruation.
- Oligo-/Amenorrhoea:irregular or absent menstruation.
- Polycystic Ovarian Syndrome (PCOS):classified by the presence of cysts on the ovaries, elevated androgens and/or absence of ovulation.
- Fibroids:benign growths within the uterine wall, commonly resulting in dysmenorrhoea and menorrhagia.
- Endometriosis:tissue that normally lines the uterus grows elsewhere (outside the uterus), resulting in dysmenorrhoea, pain during other times in the month and potentially infertility.
- Adenomyosis:tissue that normally lines the uterus grows into the inner layers of the uterus, resulting in dysmenorrhoea, menorrhagia, and infertility.
Whether the picture is mild or severe, the appearance of any of the above leads to the next logical question – what is it that causes these conditions to arise?
The Chorus, Not the Co-Stars
The simplest way to understand pretty much all female reproductive conditions is to begin with acknowledging that something has become unbalanced – but what does that actually mean, and should we be looking to the hormones themselves or not?
Let’s start with the two hormonal ‘leading ladies’ you are most likely to be familiar with: oestrogen and progesterone. These are two of the key players (along with follicle stimulating hormone (FSH) and luteinising hormone [LH]) in the cyclical, reproductive activities of the female body – rising and falling during the cycle and contributing to the maturation and release of an egg (ovulation), and the growth and development of the endometrium (uterine lining) to prepare for potential pregnancy. Typically, if fertilisation does not occur following ovulation, production of these hormones drop away, triggering the onset of monthly menstruation, beginning the cycle all over again (see Figure 1).
Figure 1: The Hormones of the Female Reproductive Cycle Rise and Fall Throughout the Month.
Female hormonal health was traditionally viewed in a simplistic way where the two main hormones, progesterone and oestrogen were either too high or too low, so raising or lowering the levels was all that was needed. For instance fibroids, endometriosis or dysmenorrhoea were purely caused by excess oestrogen and PMS, amenorrhoea were due to low progesterone.
Nowadays we understand it’s better to gauge hormonal status by assessing a hormones activity rather than just testing to see what the levels are – especially as testing hormones, in many instances, doesn’t reflect what’s actually going on inside the body.
That’s because there’s more to this hormonal tale than oestrogen and progesterone. You see, female hormonal health is also impacted by a whole troupe of other hormones and compounds. For example, thyroid hormone, insulin, androgens (e.g. testosterone) and cortisol all have the capacity to positively or negatively influence female reproductive health.
It’s a Growing Cast
Furthermore, the latest science now reveals female hormone activity is impacted by a number of additional processes, molecules and systems. For example:
- Inflammation:causes an increase in local tissue oestrogen production2(meaning oestrogen produced in places other than in the ovaries), elevates androgens,3 increases insulin levels4 and causes decreased progesterone levels.5
- Toxins, e.g. endocrine disrupting chemicals (EDCs): increase the oestrogenic load on the body, and are linked to abnormal puberty, irregular cycles, reduced fertility, PCOS, endometriosis, fibroids and early menopause.6
- Mast cells: part of the immune system, these cells can be triggered by EDCs 7and oestrogen,8 releasing a flood of inflammatory cells and histamine in the pelvic cavity. Whilst traditionally associated with allergies, mast cells are a primary contributor to the marked inflammation and pain seen with endometriosis and adenomyosis.
- Gut dysbiosis:an imbalance of the normal, healthy microbial life residing within the gastrointestinal tract can reduce the efficiency of oestrogen detoxification and elimination, increasing the overall oestrogenic load. Dysbiosis has been linked with PCOS, endometriosis and fibroids.9 We now know that a healthy microbiome is also required to detoxify EDCs from the body.10
- Brain changes:an increase in inflammation within the brain11 (caused by ongoing stress for example) alongside a reduction in neuroplasticity12 (the ability of brain structures to adapt well) is now known to play a role in PMS mood-based symptoms such as anxiety, irritability and depression.
Hormones: The Tip of the Iceberg
So as you can see, optimal female hormonal health, and conditions such as PMS, PCOS or endometriosis are not merely the result of hormonal levels. Instead, it is dysfunction across the nervous, digestive, immune, and entire hormonal system that can cause the clinical presentations listed above. As such, the way to successfully treat these conditions is to identify the upstream triggers in order to resolve the downstream hormonal symptom manifestations.
What Are Your Triggers?
The web that creates hormonal imbalance is multi-layered, complex and highly individualised to each women. Rather than trying to self-diagnose, enlist the help of a Natural Healthcare Practitioner. This can be invaluable, as we have the capacity to adeptly assess what contributing factors are at play in your unique situation based upon thorough case-taking and, in some cases, functional testing options. Our specialised knowledge allows us to craft a personalised treatment plan that will address not only your symptoms, but begin to tackle the underlying causes of them. Investing in this approach to your care is a potent way to decrease the frustration of having to figure out your own hormonal puzzle, one of the most difficult in your body!
While your hormones play a key role in your current health, they aren’t the only contributor to your overall wellbeing. If it’s time to finally understand (and then resolve) the symptoms that have you feeling trapped, exasperated, and/or in pain each month, click here to book online and begin your journey towards a more balanced and vital body today.
*Article above was compiled by Metagenics and permission was granted to be used.
- Bertone-Johnson ER. Chronic inflammation and premenstrual syndrome: a missing link found? J Womens Health (Larchmt). 2016 Sep;25(9):857-8. doi: 10.1089/jwh.2016.5937.
- Ezaki K, Motoyama H, Sasaki H. Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis. Obstet Gynecol. 2001 Nov;98(5 Pt 1):815-9.
- Gao L, Gu Y, Yin X. High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis. PLoS One. 2016 Oct 20;11(10):e0164021. doi: 10.1371/journal.pone.0164021.
- Alpañés M, Fernández-Durán E, Escobar-Morreale HF. Androgens and polycystic ovary syndrome. Expert Rev Endocrinol Metab. 2012;7(1):91–102.
- Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev. 2000 Jan;80(1):1-29.
- Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, et al. Executive Summary to EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015 Dec;36(6):593-602. doi: 10.1210/er.2015-1093.
- Kirchhoff D, Kaulfuss S, Fuhrmann U, Maurer M, Zollner TM. Mast cells in endometriosis: guilty or innocent bystanders? Expert Opin Ther Targets. 2012 Mar;16(3):237-41. doi: 10.1517/14728222.2012.661415.
- Loewendorf AI, Matynia A, Saribekyan H, Gross N, Csete M, Harrington M. Roads less traveled: sexual dimorphism and mast cell contributions to migraine pathology. Front Immunol. 2016;7:140. doi: 10.3389/fimmu.2016.00140.
- Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Oestrogen-gut microbiome axis: physiological and clinical implications. Maturitas. 2017 Sep;103:45-53. doi: 10.1016/j.maturitas.2017.06.025.
- Claus SP, Guillou H, Ellero-Simatos S. The gut microbiota: a major player in the toxicity of environmental pollutants. NPJ Biofilms Microbiomes. 2016 May 4;2:16003. doi: 10.1038/npjbiofilms.2016.3.
- Gold EB, Wells C, Rasor MO. The association of inflammation with premenstrual symptoms. J Womens Health (Larchmt). 2016 Sep;25(9):865-74. doi: 10.1089/jwh.2015.5529.
- Cubeddu A, Bucci F, Giannini A, Russo M, Daino D, Russo N, et al. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology. 2011 May;36(4):523-30. doi: 10.1016/j.psyneuen.2010.08.006.